Robert Hershberg
Director at Adaptive Biotechnologies Corp (ADPT); Director at Recursion Pharmaceuticals, Inc. (RXRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 7SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 25,000162,156 held (−13%) | $5.00 | $125K | -30.7% |
| Aug 20SEC | ADPTAdaptive Biotechnologies Corp | Sell | 15,00062,347 held (−19%) | $24.39 | $366K | -1.5% |
| Aug 20SEC | ADPTAdaptive Biotechnologies Corp | Sell | 15,66446,683 held (−25%) | $24.41 | $382K | -1.6% |
| Dec 12SEC | ADPTAdaptive Biotechnologies Corp | Sell | 22,96846,722 held (−33%) | $16.00 | $367K | +50.1% |
- Sell
Director Robert Hershberg sold $125K of RXRX at $5.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Robert Hershberg sold $382K of ADPT at $24.41 — cuts the stake by 25%.
- Sell
Director Robert Hershberg sold $367K of ADPT at $16.00 — cuts the stake by 33%.